January 29, 2018 / 1:43 PM / 10 months ago

BRIEF-LimFlow Completes Enrollment In U.S. Feasibility Study And Receives Breakthrough Device Status From FDA

Jan 29 (Reuters) -

* LIMFLOW COMPLETES ENROLLMENT IN US FEASIBILITY STUDY AND RECEIVES BREAKTHROUGH DEVICE STATUS FROM FDA FOR ITS PERCUTANEOUS DEEP VEIN ARTERIALIZATION (PDVA) SYSTEM Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below